TEL AVIV, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the quarter ended September 30, 2024. Mr. Richard Francis, Teva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback